Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marina Uchida"'
Autor:
Mariko Mouri, Mitsuru Imamura, Shotaro Suzuki, Tatsuya Kawasaki, Yoshiki Ishizaki, Keiichi Sakurai, Hiroko Nagafuchi, Norihiro Matsumura, Marina Uchida, Takayasu Ando, Kohei Yoshioka, Seido Ooka, Takahiko Sugihara, Hiroshi Miyoshi, Masaaki Mori, Tomoyuki Okada, Masao Yamaguchi, Hiroyuki Kunishima, Motohiro Kato, Kimito Kawahata
Publikováno v:
Allergology International, Vol 71, Iss 4, Pp 512-519 (2022)
Background: The mechanism of allergic reactions to COVID-19 mRNA vaccines has not been clarified. Polyethylene glycol (PEG) is a potential antigen in the components of vaccines. However, there is little evidence that allergy after COVID-19 mRNA vacci
Externí odkaz:
https://doaj.org/article/487d8d69a5f24176855c9716279742e8
Autor:
Masahide Takahashi, Yasuhiro Tanabe, Yoshihiro J. Akashi, Yusa Asari, Kimito Kawahata, Harunobu Iida, Motohiro Chosokabe, Kengo Suzuki, Yukiko Takakuwa, Marina Uchida, Takayasu Ando, Kanako Suzuki, Yoshioki Yamasaki, Nozomi Kotoku, Hidehiro Yamada
Publikováno v:
Modern Rheumatology Case Reports. 4:21-27
Acute lupus myocarditis and pulmonary arterial hypertension (PAH) are rare complications associated with systemic lupus erythematosus (SLE). No previous reports have shown the coexistence of these disorders. Here we present a 41-year-old patient with
Autor:
Marina, Uchida, Seido, Ooka, Yutaka, Goto, Kanako, Suzuki, Hisae, Fujimoto, Kana, Ishimori, Hiromi, Matsushita, Yukiko, Takakuwa, Kimito, Kawahata
Publikováno v:
Open Access Rheumatology : Research and Reviews
Purpose IL-10 is a cytokine known to inhibit inflammatory cytokines. To determine its role in the pathogenesis of systemic lupus erythematosus (SLE), the presence of anti-IL-10 antibody is required to be examined. Although antibodies against cytokine
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 40(4)
The aim of this study is to estimate the budget impact in a health insurance society and an industry of promoting decision-making for endowing grants for vaccination as prophylaxis against cervical cancer (CC) by the health insurance society for empl